Invoke Bio
1 known investors
Invoke Bio develops fully custom immunotherapies for cancer patients using proprietary AI and machine learning that models tumor-immune interactions to predict immunogenic targets. It serves patients through an expanded access program as well as biopharma companies, diagnostics firms, and research institutions.
Investors · 1
Frequently asked questions
- What does Invoke Bio do?
- Invoke Bio develops fully custom immunotherapies for cancer patients using proprietary AI and machine learning that models tumor-immune interactions to predict immunogenic targets. It serves patients through an expanded access program as well as biopharma companies, diagnostics firms, and research institutions.
- Who are Invoke Bio's investors?
- Invoke Bio's investors include HCVC.